MD2 ECONOMIC CONSEQUENCES OF PROVIDING RITUXIMAB AS ATREATMENT ALTERNATIVE FOR RHEUMATOID ARTHRITIS IN THE NETHERLANDS
M Pompen, A Diamantopoulos, W Kievit, R Moers, A KielhornVolume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)64897-8
File:
PDF, 93 KB
english, 2007